Literature DB >> 12460468

Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma.

Yutaka Takahashi1, Yasuhiko Kitadai, Lee M Ellis, Corazon D Bucana, Isaiah J Fidler, Masayoshi Mai.   

Abstract

We examined the expression level of several genes that regulate different steps in metastasis formation in formalin-fixed, paraffin-embedded biopsies of 189 primary human gastric carcinomas prior to surgical resection in patients in whom lymph node metastasis was not evident by endoscopic ultrasound or computed tomography (CT) scan. The expressions of epidermal growth factor receptor (EGF-R), vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and E-cadherin were examined by a colorimetric in situ mRNA hybridization technique. The integrity of the mRNAs was verified, leaving 161 (85.2%) patients for study. After gastrectomy, 82 patients had positive lymph nodes and 79 patients had negative lymph nodes. The concurrent expression levels of MMP-2 and E-cadherin mRNAs were significantly higher and lower, respectively, in the metastatic tumors than the non-metastatic tumors. Expression of EGF-R and VEGF was not different between the metastatic and non-metastatic tumors. However, when only the intestinal-type of gastric cancer was evaluated, the level of VEGF mRNA was significantly higher in tumors associated with lymph node metastasis than in those without metastasis. However, a high MMP-2:E-cadherin ratio significantly correlated with lymph node metastasis in both types of gastric cancer. These results suggest that multiparametric in situ hybridization analysis for several metastasis-related genes may allow the preoperative prediction of lymph node metastasis from gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460468      PMCID: PMC5926890          DOI: 10.1111/j.1349-7006.2002.tb01232.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  54 in total

1.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

Authors:  G F Greene; Y Kitadai; C A Pettaway; A C von Eschenbach; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.

Authors:  A D'Errico; S Garbisa; L A Liotta; V Castronovo; W G Stetler-Stevenson; W F Grigioni
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

4.  Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma.

Authors:  Y Kitadai; L M Ellis; S L Tucker; G F Greene; C D Bucana; K R Cleary; Y Takahashi; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 5.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

6.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

8.  Increased expression of the epidermal growth factor receptor on human colon carcinoma cells.

Authors:  S J Bradley; G Garfinkle; E Walker; R Salem; L B Chen; G Steele
Journal:  Arch Surg       Date:  1986-11

9.  Tissue status of epidermal growth factor and its receptor as an indicator of poor prognosis in patients with gastric cancer.

Authors:  Y Yonemura; K Sugiyama; S Fushida; T Kamata; S Ohoyama; H Kimura; A Yamaguchi; I Miyazaki
Journal:  Anal Cell Pathol       Date:  1991-11       Impact factor: 2.916

10.  Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.

Authors:  Y Takahashi; K R Cleary; M Mai; Y Kitadai; C D Bucana; L M Ellis
Journal:  Clin Cancer Res       Date:  1996-10       Impact factor: 12.531

View more
  6 in total

Review 1.  The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.

Authors:  Weisong Shen; Hongqing Xi; Bo Wei; Lin Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-08       Impact factor: 4.553

2.  Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.

Authors:  Ge Lou; Ying Gao; Xiao-Ming Ning; Qi-Fan Zhang
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

3.  Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma.

Authors:  Ze-Yu Wu; Jing-Hua Li; Wen-Hua Zhan; Yu-Long He
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

4.  VEGFA and VEGFR2 RNAscope determination in gastric cancer.

Authors:  Roberto Tamma; Tiziana Annese; Simona Ruggieri; Andrea Marzullo; Beatrice Nico; Domenico Ribatti
Journal:  J Mol Histol       Date:  2018-05-14       Impact factor: 2.611

5.  Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.

Authors:  Chun-Gen Xing; Bao-Song Zhu; Xiao-Qing Fan; Hui-Hui Liu; Xun Hou; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

6.  Blockade of NF-κB nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells.

Authors:  Zhi-Min Li; Yu-Wei Pu; Bao-Song Zhu
Journal:  Oncol Lett       Date:  2013-06-11       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.